Inside R&D Alert. Novel Approach Discovered To Target Acute Myeloid Leukemia; Promising Injectable Treatment for Wounded Soldiers; Nanomaterial Barrier for Sensitive Teeth

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles discovery of an approach to target acute myeloid leukemia, a promising injectable treatment for wounded soldiers, and a nanomaterial barrier for sensitive teeth.

Table of Contents

Inside R&D Alert. Novel Approach Discovered To Target Acute Myeloid Leukemia; Promising Injectable Treatment for Wounded Soldiers; Nanomaterial Barrier for Sensitive TeethIn This Issue1. NOVEL APPROACH DISCOVERED TO TARGET ACUTE MYELOID LEUKEMIA2. PROMISING INJECTABLE TREATMENT FOR WOUNDED SOLDIERS3. NOVEL SOFTWARE HIGHLIGHTS MOST EFFECTIVE ROOFTOPS FOR SOLAR PANEL INSTALLATION4. NANOMATERIAL BARRIER FOR SENSITIVE TEETH




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.